FCHV-HTN Implementation Trial in Nepal
CHPC
Community Health Worker Led Hypertension Prevention and Control (CHPC) in Nepal: An Implementation Trial
2 other identifiers
interventional
3,572
1 country
1
Brief Summary
The goal of this hybrid type III study incorporating a cluster-randomized trial is to assess the effect of a community health worker-led hypertension prevention and control program (CHPC) on the implementation outcomes and clinical outcomes among patient with hypertension in central Nepal. The main questions it aims to answer are: 1\. What is the level of implementation outcomes, including reach, adoption, implementation fidelity, and maintenance of the CHPC implementation strategy at the patient, provider, and health system levels? 2: What is the effectiveness of the CHPC implementation strategy compared to facility-based intervention on systolic BP via a cluster randomized controlled trial. 3: What is the implementation cost and cost-effectiveness of the CHPC implementation strategy? Participants will receive four follow-up group meetings or home visits every three months for a year by a community health worker. Researchers will compare if there is a significant difference in systolic blood pressure between those who receive this intervention and those who do not receive the intervention in the same community.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Dec 2024
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2023
CompletedFirst Posted
Study publicly available on registry
October 12, 2023
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 6, 2026
February 1, 2026
3.1 years
October 6, 2023
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Reach
Percentage of CHWs implementing the program
12 months
Adoption
Percentage of the health facilities asked to participate in adopting the program
12 months
Program implementation
Percent of the health facility will implement a minimum standard to program implementation
12 months
Maintenance
Percentage of the health facility that will implement a minimum standard to program implementation during the maintenance period
24 months
Secondary Outcomes (12)
Blood Pressure
12 months
Hypertension Diagnosis Awareness
12 months
Blood Pressure Control
12 months
Physical activity
12 months
Fruits and Vegetables
12 months
- +7 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALCommunity Health Worker Intervention
Control Group
NO INTERVENTIONUsual care that includes patients visit to health facility based on felt need
Interventions
Trained CHWs will hold group meetings or home visits using a locally adapted manual for HTN management. CHWs will visit homes in their areas and measure BP. High BP clients will be taken to the nearest health center. CHWs will enroll individuals with preHTN and HTN and conduct 4 follow-up group meetings or home visits with them every 3 months. Participants will be invited to attend CHW lead group-based counseling. For those with uncontrolled HTN who have difficulty adhering to prescribed HTN management and not willing or able to attend group meetings, CHWs will conduct follow-up home visits. First meeting (about 90 minutes), CHWs will explain purpose of the meeting and discuss HTN and its consequences. CHWs will apply techniques to initiate dialogue and reflection regarding lifestyle modifications and choose goals based on PEN protocol-2, BP monitoring, and antihypertensive medication use. In subsequent meetings (about 60 minutes), the CHWs will measure BP and address ongoing problems.
Eligibility Criteria
You may qualify if:
- High blood pressure (BP) of 140/90 mmHg or higher.
You may not qualify if:
- Severe illness requiring bed rest
- Pregnant women, due to their special health needs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- Dhulikhel Hospitalcollaborator
- Institute for Implementation Science and Healthcollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Dhulikhel Hospital
Dhulikhel, Nepal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Donna Spiegelman, ScD
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2023
First Posted
October 12, 2023
Study Start
December 2, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share